Novo Nordisk A/S
NYSE:NVO

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
NYSE:NVO
Watchlist
Price: 62.33 USD Market Closed
Market Cap: 277.6B USD

Profitability Summary

Novo Nordisk A/S's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Novo Nordisk A/S

Margins Comparison
Novo Nordisk A/S Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.8B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
DE
Bayer AG
XETRA:BAYN
42.3B EUR
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.8B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.1B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
218.9B CHF
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Novo Nordisk A/S Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
177.8B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
Loading...
DE
Bayer AG
XETRA:BAYN
42.3B EUR
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
273.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.1B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
218.9B CHF
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Novo Nordisk A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate